Delivery Order SPE2DE21D7020-SPE2D626F4202
- Not listed
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $18,134.55 for agent drug-coated balloons by the Defense Health Agency's Medical Supply Chain on August 8, 2025. The delivery order, which carries an ultimate completion date of August 15, 2025, represents a competitive award with no set-aside designation. The contract employs fixed-price pricing with economic price adjustment mechanisms...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $18,953.95 for agent drug-coated balloon supplies. The contract, awarded on June 6, 2025, with an ultimate completion date of June 11, 2025, is funded through the Defense Health Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment represents Boston Scientific's continued role as a critical supplier...
- Boston Scientific Corp has been awarded a delivery order valued at $100,752.05 by the Defense Health Agency's Medical Supply Chain division for Agent drug-coated balloons. The delivery order, issued on October 14, 2025, carries a fixed-price contract structure with economic price adjustment provisions and will be completed by October 21, 2025. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This delivery order was issued without a small business...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $22,101.25 for drug-coated balloons under a Defense Health Agency Medical Supply Chain contract. The award, issued on May 30, 2025, with an ultimate completion date of June 6, 2025, represents a fixed-price contract with economic price adjustment provisions. The contract is not set aside for any specific business category and will be performed at...
- Boston Scientific Corp has been awarded a $48,157.20 fixed-price delivery order with economic price adjustment by the Defense Health Agency's Medical Supply Chain for agent drug-coated balloons. The contract, issued on September 8, 2025, carries an ultimate completion date of September 15, 2025, and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This delivery order represents a non-set-aside award, indicating open competition in the federal marketplace, and...
- Boston Scientific Corp has been awarded a delivery order valued at $8,150.20 for agent drug-coated balloons under a Defense Health Agency Medical Supply Chain contract. The award, issued on September 16, 2025, with a completion date of September 19, 2025, utilizes fixed-price pricing with economic price adjustment terms. The contract carries no set-aside designation, indicating open competition in the federal marketplace. Performance will be executed at Boston Scientific's Marlborough,...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $55,947.15 by the Defense Health Agency's Medical Supply Chain on July 29, 2025, with an ultimate completion date of August 5, 2025. The contract, which carries no set-aside designation, calls for the delivery of Ranger Global DCB (drug-coated balloon) devices measuring 4.0 x 120mm with a 150cm length. Performance will take place at Boston...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order contract valued at $1,974.29 by the Defense Health Agency's Medical Supply Chain on July 2, 2025, with an ultimate completion date of July 10, 2025. The contract, issued without a set-aside designation, covers the procurement of a Ranger Global DCB (drug-coated balloon) OTW (over-the-wire) 7.0 x 60mm 80cm medical device. The contract employs fixed-price...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $6,175 to Boston Scientific Corp on September 24, 2025, for the supply of agent drug-coated balloons. The contract is a fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of October 1, 2025. Boston Scientific will fulfill this order from its Marlborough, Massachusetts facility, where the company manufactures advanced medical devices. No small business set-aside...
- Boston Scientific Corp has been awarded a delivery order valued at $6,175.00 for agent drug-coated balloons under the Defense Health Agency's Medical Supply Chain contract vehicle. The award, issued on August 15, 2025, with an ultimate completion date of August 22, 2025, represents a fixed-price contract with economic price adjustment provisions. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts, the company's headquarters location. This delivery order...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D626F4202Delivery Order
Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $74,214.22 by the Defense Health Agency's Medical Supply Chain division on October 23, 2025. The delivery order covers Agent drug-coated balloons, which are used in cardiovascular interventional procedures. This fixed-price contract with economic price adjustment features has an ultimate completion date of October 30, 2025, and was issued without a small business set-aside, allowing Boston Scientific to compete on an unrestricted basis. The contract represents a task order issued against Boston Scientific's broader relationship with the Defense Health Agency's Medical Supply Chain, through which the company supplies specialized medical devices to military healthcare facilities and Veterans Affairs medical centers. This award reflects Boston Scientific's established position as a critical supplier of cardiovascular and interventional medical devices to the federal healthcare enterprise. The company maintains an extensive portfolio of federal contracts encompassing pacemakers, stents, ablation systems, and various other advanced medical technologies across multiple Veterans Integrated Service Networks and the Defense Health Agency. The relatively short performance window and specific focus on Agent drug-coated balloons indicate this delivery order addresses immediate resupply requirements within the defense and veterans healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $74.2k | 10/23/25 |